Bender Robert & Associates Abbott Laboratories Transaction History

Bender Robert & Associates

$471 Million
Q3 2024

A detailed history of Bender Robert & Associates transactions in Abbott Laboratories stock. As of the latest transaction made, Bender Robert & Associates holds 5,771 shares of ABT stock, worth $681,728. This represents 0.14% of its overall portfolio holdings.

Number of Shares

5,771

Previous 5,811 0.69%

Holding current value

$681,728

Previous $603,000 8.96%

% of portfolio

0.14%

Previous 0.13%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$100.07 - $118.13 $577,503 - $681,728	5,771 New	5,771 $657,000
Q1 2024 Apr 22, 2024	SELL	$109.52 - $120.96 $34,717 - $38,344	-317 Reduced 4.44%	6,817 $774,000
Q4 2023 Jan 31, 2024	SELL	$90.19 - $110.4 $16,414 - $20,092	-182 Reduced 2.49%	7,134 $785,000
Q3 2023 Oct 13, 2023	SELL	$95.53 - $114.62 $78,812 - $94,561	-825 Reduced 10.13%	7,316 $708,000
Q2 2023 Jul 13, 2023	SELL	$100.78 - $112.29 $58,452 - $65,128	-580 Reduced 6.65%	8,141 $887,000
Q1 2023 Apr 20, 2023	SELL	$96.86 - $114.01 $484 - $570	-5 Reduced 0.06%	8,721 $883,000
Q4 2022 Feb 02, 2023	SELL	$95.06 - $111.52 $24,715 - $28,995	-260 Reduced 2.89%	8,726 $958,000
Q3 2022 Oct 26, 2022	BUY	$96.76 - $112.03 $27,092 - $31,368	280 Added 3.22%	8,986 $869,000
Q2 2022 Jul 19, 2022	SELL	$102.07 - $123.37 $3,572 - $4,317	-35 Reduced 0.4%	8,706 $946,000
Q1 2022 Apr 14, 2022	SELL	$114.02 - $139.04 $26,794 - $32,674	-235 Reduced 2.62%	8,741 $1.04 Million
Q3 2021 Nov 03, 2021	SELL	$116.66 - $129.06 $13,999 - $15,487	-120 Reduced 1.32%	8,976 $1.06 Million
Q2 2021 Jul 16, 2021	BUY	$105.79 - $124.53 $6,347 - $7,471	60 Added 0.66%	9,096 $1.05 Million
Q2 2020 Jul 31, 2020	BUY	$76.57 - $98.0 $382 - $490	5 Added 0.06%	9,036 $826,000
Q1 2020 Apr 21, 2020	SELL	$62.82 - $91.86 $5,339 - $7,808	-85 Reduced 0.93%	9,031 $713,000
Q4 2019 Jan 31, 2020	SELL	$78.51 - $87.4 $4,318 - $4,807	-55 Reduced 0.6%	9,116 $792,000
Q3 2019 Oct 15, 2019	SELL	$81.84 - $88.74 $9,411 - $10,205	-115 Reduced 1.24%	9,171 $767,000
Q2 2019 Jul 30, 2019	SELL	$72.88 - $85.0 $84,905 - $99,025	-1,165 Reduced 11.15%	9,286 $815,000
Q1 2019 Apr 30, 2019	SELL	$66.22 - $80.06 $41,056 - $49,637	-620 Reduced 5.6%	10,451 $835,000
Q4 2018 Jan 24, 2019	SELL	$65.56 - $74.27 $14,423 - $16,339	-220 Reduced 1.95%	11,071 $801,000
Q3 2018 Oct 17, 2018	SELL	$60.81 - $73.36 $4,864 - $5,868	-80 Reduced 0.7%	11,291 $828,000
Q2 2018 Jul 27, 2018	SELL	$57.57 - $63.54 $18,422 - $20,332	-320 Reduced 2.74%	11,371 $694,000
Q1 2018 Apr 27, 2018	SELL	$56.27 - $63.62 $8,721 - $9,861	-155 Reduced 1.31%	11,691 $701,000
Q4 2017 Jan 19, 2018	SELL	$53.68 - $57.47 $15,567 - $16,666	-290 Reduced 2.39%	11,846 $676,000
Q3 2017 Oct 23, 2017	BUY	$48.06 - $53.64 $583,256 - $650,975	12,136	12,136 $648,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bender Robert & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Bender Robert & Associates with notifications on news.

Account

Bender Robert & Associates Abbott Laboratories Transaction History